Join to access to all OVN content. Join for Free

Results for 'In Vitro-to-In Vivo'

Browse oncology articles matching In Vitro-to-In Vivo — expert analysis, clinical perspectives, and industry updates from across drug development and care delivery. Use the tabs above for podcasts, press releases, partners, and people for the same search.

In Vitro-to-In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
OVN Avatar Jingjing Yu, Isabelle Ragueneau-Majlessi
In Vitro-to-In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018

In Vitro-to-In Vivo, Transporter Inhibition Data, Drug Approval, FDA, 2018

The analysis focuses on inhibition transporter data from New Drug Applications approved by the FDA in 2018, involving 42 drugs. Key points include: In vitro-to-in vivo predictions were available for nine recommended transporters. 29 parent drugs and 16 metabolites inhibited at least one transpor…

Jan 25th • 12 mins read

Related Topics

Meet Our Innovation Partners

Loading partners...